FI885101A0 - Förfarande för framställning av läkemedels kontrollerat frigörande dosform - Google Patents

Förfarande för framställning av läkemedels kontrollerat frigörande dosform

Info

Publication number
FI885101A0
FI885101A0 FI885101A FI885101A FI885101A0 FI 885101 A0 FI885101 A0 FI 885101A0 FI 885101 A FI885101 A FI 885101A FI 885101 A FI885101 A FI 885101A FI 885101 A0 FI885101 A0 FI 885101A0
Authority
FI
Finland
Prior art keywords
dosage form
controlled release
release dosage
medicament
preparation
Prior art date
Application number
FI885101A
Other languages
English (en)
Finnish (fi)
Other versions
FI885101A (sv
FI96273C (sv
FI96273B (sv
Inventor
Masayoshi Samejima
Kazuo Noda
Masao Kobayashi
Shigeyuki Ishikawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI885101A0 publication Critical patent/FI885101A0/sv
Publication of FI885101A publication Critical patent/FI885101A/sv
Application granted granted Critical
Publication of FI96273B publication Critical patent/FI96273B/sv
Publication of FI96273C publication Critical patent/FI96273C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI885101A 1987-11-06 1988-11-04 Förfarande för framställning av läkemedels kontrollerat frigörande dosform FI96273C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28118987 1987-11-06
JP28118987 1987-11-06

Publications (4)

Publication Number Publication Date
FI885101A0 true FI885101A0 (sv) 1988-11-04
FI885101A FI885101A (sv) 1989-05-07
FI96273B FI96273B (sv) 1996-02-29
FI96273C FI96273C (sv) 1996-06-10

Family

ID=17635585

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885101A FI96273C (sv) 1987-11-06 1988-11-04 Förfarande för framställning av läkemedels kontrollerat frigörande dosform

Country Status (24)

Country Link
US (1) US4963365A (sv)
EP (1) EP0315414B1 (sv)
KR (1) KR940002655B1 (sv)
CN (1) CN1035099C (sv)
AT (1) ATE68343T1 (sv)
AU (1) AU610275B2 (sv)
BG (1) BG60638B1 (sv)
CA (1) CA1331565C (sv)
DE (1) DE3865631D1 (sv)
DK (1) DK175249B1 (sv)
ES (1) ES2027013T3 (sv)
FI (1) FI96273C (sv)
FR (1) FR2622799B1 (sv)
GR (1) GR3002915T3 (sv)
HK (1) HK44593A (sv)
HU (1) HU201468B (sv)
IE (1) IE60785B1 (sv)
IL (1) IL88083A (sv)
NO (1) NO176233C (sv)
PH (1) PH25905A (sv)
PT (1) PT88945B (sv)
RU (1) RU1816213C (sv)
SG (1) SG15493G (sv)
ZA (1) ZA888147B (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
DK0386440T3 (da) * 1989-02-11 1992-09-14 Bayer Ag Lægemidler med kontrolleret afgivelse af virksomt stof
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
EP0722735A1 (en) * 1989-03-22 1996-07-24 PANG, Peter K. T. Parathyroid hypertensive factor
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
EP0585355B1 (en) * 1991-05-20 1995-03-22 Marion Laboratories, Inc. Multi-layered controlled release formulation
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
DE69327745T2 (de) * 1992-05-29 2000-09-21 Nikken Chemicals Co Ltd Tablette zur langsamen Freisetzung von Natriumvalproat
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
TW477708B (en) * 1996-09-13 2002-03-01 Shionogi & Amp Co Use of the thermal change to produce a substained release preparations and a process for their production
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
KR100396171B1 (ko) * 1998-08-10 2003-08-27 아사히 가세이 가부시키가이샤 염산 파수딜의 경구 서방성 제제
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
NZ528957A (en) 2001-04-18 2005-05-27 Nostrum Pharmaceuticals Inc A novel coating for a sustained release pharmaceutical composition
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
CN1296046C (zh) * 2003-12-23 2007-01-24 广州市医药工业研究所 盐酸地尔硫䓬控释胶囊剂及其制备方法
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8088414B2 (en) 2006-02-07 2012-01-03 Fmc Corporation Latex or pseudolatex compositions, coatings and coating processes
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) * 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) * 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8927010B2 (en) * 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
CN102805733B (zh) * 2011-06-01 2016-03-09 日东电工株式会社 颗粒制剂及其制造方法
FR2996418B1 (fr) * 2012-10-09 2015-05-29 Seppic Sa Compositions alimentaires comprenant des capsules obtenues par coacervation ne mettant pas en œuvre de reticulant toxique
KR102237799B1 (ko) 2012-11-14 2021-04-08 더블유.알. 그레이스 앤드 캄파니-콘. 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1172087A (fr) * 1956-01-25 1959-02-05 Bellon Labor Sa Roger Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4390406A (en) * 1982-07-23 1983-06-28 Allied Corporation Replaceable outer junction double junction reference electrode
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins

Also Published As

Publication number Publication date
DK175249B1 (da) 2004-07-19
ZA888147B (en) 1990-06-27
FR2622799B1 (fr) 1991-11-29
DK618088A (da) 1989-05-07
IL88083A0 (en) 1989-06-30
FI885101A (sv) 1989-05-07
PT88945A (pt) 1989-11-30
KR890007720A (ko) 1989-07-05
FI96273C (sv) 1996-06-10
CN1033007A (zh) 1989-05-24
GR3002915T3 (en) 1993-01-25
HUT50624A (en) 1990-03-28
IL88083A (en) 1992-11-15
DK618088D0 (da) 1988-11-04
NO176233C (no) 1995-03-01
NO884947D0 (no) 1988-11-04
ATE68343T1 (de) 1991-11-15
US4963365A (en) 1990-10-16
PH25905A (en) 1991-12-19
IE60785B1 (en) 1994-08-10
ES2027013T3 (es) 1992-05-16
CN1035099C (zh) 1997-06-11
SG15493G (en) 1993-04-16
AU610275B2 (en) 1991-05-16
CA1331565C (en) 1994-08-23
KR940002655B1 (ko) 1994-03-28
PT88945B (pt) 1993-05-31
IE883246L (en) 1989-05-06
BG60638B1 (bg) 1995-11-30
FI96273B (sv) 1996-02-29
FR2622799A1 (fr) 1989-05-12
DE3865631D1 (de) 1991-11-21
HU201468B (en) 1990-11-28
AU2472788A (en) 1989-05-11
NO176233B (no) 1994-11-21
NO884947L (no) 1989-05-08
EP0315414B1 (en) 1991-10-16
EP0315414A1 (en) 1989-05-10
RU1816213C (ru) 1993-05-15
HK44593A (en) 1993-05-14

Similar Documents

Publication Publication Date Title
FI96273B (sv) Förfarande för framställning av läkemedels kontrollerat frigörande dosform
FI101344B1 (sv) Förfarande för framställning av ett preparat för kontrollerat frigöring av ett farmaceutiskt aktivt ämne
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
NO904754D0 (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
DK285690A (da) Farmaceutisk doseringsform til medicinsk behandling af fisk
SE8701479L (sv) Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: TANABE SEIYAKU CO., . LTD.

MA Patent expired